Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer

Zeda Zhang(Memorial Sloan Kettering Cancer Center), Charles L. Sawyers(Memorial Sloan Kettering Cancer Center), Wouter R. Karthaus(École Polytechnique Fédérale de Lausanne), Anuradha Gopalan(Memorial Sloan Kettering Cancer Center), Menghan Liu(Capital Medical University), Xuejun Jiang(Zhejiang University), Brett S. Carver(Memorial Sloan Kettering Cancer Center), HuiYong Zhao(Memorial Sloan Kettering Cancer Center), John Wongvipat(Memorial Sloan Kettering Cancer Center), Vianne R. Gao(Memorial Sloan Kettering Cancer Center), Joshua W. Russo(Beth Israel Deaconess Medical Center), José Maurício Mota(Universidade de São Paulo), Wassim Abida(Memorial Sloan Kettering Cancer Center), Hsuan-An Chen(Memorial Sloan Kettering Cancer Center), Ping Mu(Yale Cancer Center), Eugine Lee(Memorial Sloan Kettering Cancer Center), Katia Manova‐Todorova(Memorial Sloan Kettering Cancer Center), Eliot Linton(Memorial Sloan Kettering Cancer Center), Chao Wu(Memorial Sloan Kettering Cancer Center), Spencer Barnes(Southwestern Medical Center), Steven P. Balk(Beth Israel Deaconess Medical Center), Danielle Choi(Memorial Sloan Kettering Cancer Center), Young Sun Lee(Memorial Sloan Kettering Cancer Center), Xiaoping Chen(Memorial Sloan Kettering Cancer Center), Philip A. Watson(Memorial Sloan Kettering Cancer Center), Mary-Ellen Taplin(Dana-Farber Brigham Cancer Center), Dana E. Rathkopf(Memorial Sloan Kettering Cancer Center), Ninghui Mao(Memorial Sloan Kettering Cancer Center), Elisa de Stanchina(Memorial Sloan Kettering Cancer Center)
Cancer Cell
July 16, 2020
Cited by 252


Related Papers